pharmaceutical-market

Image for Bristol Myers plans UK launch of schizophrenia drug Cobenfy, matching US priceHeadlines

Bristol Myers Plans UK Launch of Schizophrenia Drug Cobenfy, Matching US Price

Image for Roche, muscling into weight-loss drug race, advances obesity treatment to late-stage trialHeadlines

Roche, Muscling Into Weight-Loss Drug Race, Advances Obesity Treatment to Late-Stage Trial

Image for Europe struggles with chronic drug shortages, auditors warnHeadlines

Europe Struggles With Chronic Drug Shortages, Auditors Warn

Image for Lilly weight-loss pill could be FDA-approved by year-endHeadlines

Lilly Weight-Loss Pill Could Be FDA-approved by Year-End

Image for Private equity GTCR strikes $4.8 billion deal to buy Zentiva, FT reports

Private Equity Gtcr Strikes $4.8 Billion Deal to Buy Zentiva, Ft Reports

Date: September 11, 2025

(Reuters) -GTCR has struck a 4.1 billion-euro ($4.80 billion) deal to buy Czech generic drug maker Zentiva from Advent International, the Financial Times reported on Wednesday, citing two people...

Image for British pharma industry says drug pricing stance hurts foreign investment

British Pharma Industry Says Drug Pricing Stance Hurts Foreign Investment

Date: September 10, 2025

LONDON (Reuters) -Britain's main pharmaceutical lobby group said on Wednesday foreign investment in the sector has fallen due to its approach to drug pricing, as the industry remains locked in dispute...

Image for Netherlands pushes for more generic drug imports from India

Netherlands Pushes for More Generic Drug Imports From India

Date: September 5, 2025

By Rishika Sadam and Sriparna Roy NEW DELHI (Reuters) -The Netherlands is aiming to increase imports of Indian generic drugs into the country, as it looks to diversify its portfolio and avoid supply...

Image for India looking beyond US for pharma exports amid tariff tensions

India Looking Beyond US for Pharma Exports Amid Tariff Tensions

Date: September 4, 2025

By Sriparna Roy and Rishika Sadam NEW DELHI (Reuters) -India is seeking to boost drug exports to semi-regulated markets in Africa, Latin America and Southeast Asia to reduce its dependence on the U.S....

Image for AstraZeneca to seek approval for blood pressure drug by year-end

AstraZeneca to Seek Approval for Blood Pressure Drug by Year-End

Date: August 30, 2025

By Pushkala Aripaka (Reuters) -AstraZeneca plans to file for regulatory approval of its experimental blood pressure treatment before the end of the year, a senior company executive said, about a...

Image for India's Aurobindo Pharma leads race to buy generic drugmaker Zentiva for $5.5 billion, Economic Times reports

India's Aurobindo Pharma Leads Race to Buy Generic Drugmaker Zentiva for $5.5 Billion, Economic Times Reports

Date: August 20, 2025

(Reuters) -India's Aurobindo Pharma is leading the race to buy Prague-based drugmaker Zentiva for up to $5.5 billion, the Economic Times reported on Wednesday, in what could be the largest-ever...